key: cord-0880336-lgkfkuh1
authors: Wik, Jonas Aakre; Skålhegg, Bjørn Steen
title: T Cell Metabolism in Infection
date: 2022-03-14
journal: Front Immunol
DOI: 10.3389/fimmu.2022.840610
sha: cfc4488831821629556b1314599354937285c07b
doc_id: 880336
cord_uid: lgkfkuh1

T lymphocytes (T cells) are divided into two functionally different subgroups the CD4+ T helper cells (Th) and the CD8+ cytotoxic T lymphocytes (CTL). Adequate CD4 and CD8 T cell activation to proliferation, clonal expansion and effector function is crucial for efficient clearance of infection by pathogens. Failure to do so may lead to T cell exhaustion. Upon activation by antigen presenting cells, T cells undergo metabolic reprograming that support effector functions. In this review we will discuss how metabolic reprograming dictates functionality during viral infections using severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human immunodeficiency virus (HIV) as examples. Moreover, we will briefly discuss T cell metabolic programs during bacterial infections exemplified by Mycobacterium tuberculosis (MT) infection.

The secretion of proinflammatory cytokines, interaction between the Fas ligand and Fas receptor, and the secretion of cytolytic granules containing perforin, which creates pores in the target cell allowing the entry of proteases, including Granzyme B, that induce apoptosis (6, 7) . CD4+ T cells are indirectly involved in clearing infection by modulating the activity of other immune cells, including macrophages (Mø), neutrophils, B cells and CTLs (2) . CD4+ T cells can be grouped into several subsets and include T helper (Th) 1 (Th1), Th2, Th9, Th17, Th22 as well as follicular helper T (Tfh) cells and regulatory T cells (Tregs) . The CD4+ T cell subsets are defined by the distinct expression of surface molecules and endogenous production of cytokines, which are driven by the presence of extracellular cytokines and activation of key transcription factors (8) . Tfh cells are primarily involved in promoting survival, proliferation and class-switching of germinal center B cells and support germinal center development. Th1, Th2, Th9, Th17, and Th22 subsets, on the other hand, are involved in host defense against specific microbial pathogens. The Th1 and Th2 subsets were the first Th cell subsets to be identified. Whereas Th1 cells kill intracellular bacteria through activating Mø and CTLs, Th2 cells are drivers of immune reactions directed against extracellular parasites (8, 9) . Th17 cells, which are characterized by the transcription factor retinoic acid receptor (RAR)-related orphan receptor g (RORg) and production of the cytokines IL-17A, IL-17F, IL-21 and IL-22, are involved in protection against pathogens on mucosal surfaces (8, (10) (11) (12) . Th22 cells also secrete IL-22, but in contrast to Th17 cells, do not secrete IL-17 nor express RORg (13) . As Th22 cells are mainly found in the skin where IL-22 induces expression of antimicrobial peptides in keratinocytes and epithelial cells they are likely involved in maintaining homeostasis in skin (13, 14) . Th9 cells, which are characterized by the secretion of IL-9, are involved in immune responses towards extracellular parasites, allergic inflammation and anti-tumor immune response. Interestingly, the anti-tumor functions of Th9 cells were found to be superior as compared to Th1 and other Th subsets and involves activation of the innate and adaptive immune system, including, generation of a profound CTL response against neo antigens (15, 16) . Recently, it has also become evident that CD4+ subset of T cells can be cytotoxic themselves. These cytotoxic CD4+ T cells can induce cell death through interacting with peptides presented on MHC II, similar to CD8+ CTLs (17) . While the CD4+ subsets are crucial in clearing infection, dysregulation may also result in pathological conditions including autoimmune diseases, allergy and asthma (14, 15, 18, 19) . While Th1 and Th17 cells are implicated in autoimmunity and Th2 cells are involved in allergic immune responses, Th22 cells appear to be involved in both autoimmunity and allergy (14, (20) (21) (22) . Th9 cells have recently been implicated in tumor immunity and promoting tolerance to transplanted organs (15, 23, 24) . The activities of T cell subsets are balanced in part by unique CD4+ Treg T cell subpopulation. Tregs are vital to immune homeostasis and self-tolerance, dampening inflammation, and preventing the development of autoimmune disease, but may also be involved in promoting cancer progression (25) . The balance between pro-inflammatory and anti-inflammatory signals is critically important.

It is widely accepted that the fundamental processes in T cell biology, such as T cell activation, differentiation and effector functions are closely linked to changes in the cellular metabolic programs. Key metabolic pathways such as glycolysis, fatty acid synthesis and mitochondrial metabolism play a crucial role in T cell immunometabolism (26) .

T cell metabolism is crucial for maintaining homeostasis in naïve and memory cells, while also priming cells for rapid activation. Additionally, T cell metabolism drives and mirrors the activation and differentiation states of T cells. The focus of this section will be on how activation of T cells and metabolism are related as well as how metabolic reprograming drives the phenotype of activated T cells.

Naïve T cells enter the circulation from the thymus and are actively maintained in a reversible form of cell cycle arrest by a combination of self-peptide-MHC engagement of the TCR/CD3 and by interleukin (IL)-7 stimulation (27) . Activation of T cells leads to exit of the quiescent state, inducing cell growth, clonal expansion and differentiation. This process is initiated and regulated by three key factors, perturbation of cell surface receptors, nutrient availability and oxygen levels (28) .

The magnitude of acute T cell activation depends on activation of the TCR and co-stimulation of a group of T cell surface coreceptors. These co-receptors include the CD3, CD4, CD8 CD28/ CTLA4 and more (29) . As mentioned, the CD4 and CD8 molecules directly interact with the MHC II and MHC I molecules, respectively, and influence the early mode of T cell activation. Interaction between the MHC-peptide complex and CD4/CD8 co-receptors is recognized by the TCR, leading to activation of a signaling complex composed of the protein tyrosine kinase (PTK) C-terminal Src kinase (Csk) and lymphocyte-specific protein kinase (Lck). These kinases phosphorylate the immunoreceptor tyrosine kinase-based activation motifs (ITAMs) on the z-chain of CD3. This induces downstream signaling by the recruitment, phosphorylation and activation of the zeta-chain associated protein kinase 70 (ZAP70). ZAP70 initiates a downstream signaling cascade and includes activation of phospholipase Cg1 (PLCg1), which promotes calcium mobilization, activation of protein kinase C (PKC) and activation of Ras pathway (30) (31) (32) . The combination of these signaling cascades promotes activation of several transcription factors, including Nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB), Nuclear factor of activated T-cells (NFAT) and Activator protein 1 (AP-1). This leads to production and secretion of the T cell-specific growth factor IL-2 (33) (34) (35) (36) (37) (38) . The costimulatory receptor CD28 interacts with its ligands CD80 and CD86, which are differentially expressed by APCs. CD86 is constitutively expressed on APCs, while expression of CD80 is induced by stimulation of Toll-like receptors (TLRs) (39) . Activation of CD28 leads to cross phosphorylation of intrinsic CD28 receptor tyrosine residues followed by attachment and activation of phosphatidylinositol kinase 3 (PI3K) (40, 41) . PI3K phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5 phosphate (PIP3), leading to activation of protein kinase B (PKB or Akt) and NFkB. This pathway regulates T cell survival through the expression of the antiapoptotic gene B-cell lymphoma-extra-large (BCL-XL) and Aktdependent upregulation of IL-2 production (39). CTLA4, however, is considered an inhibitory receptor and stimulation will, to some extent, suppress TCR/CD3-CD28 induced activation by competing with CD28 for CD80/86. Perturbation of the CTLA4 receptor will lead to the recruitment of endogenous protein tyrosine and serine/ threonine phosphatases. This includes Src homology protein 2 domain-containing tyrosine phosphatase 2 (SHP-2) and protein phosphatase 2A (PP2A). This will lead to dephosphorylation and inhibition of several proteins in the signaling pathway, including ZAP70, consequently reducing the activation, growth and clonal expansion of T cells (42) (43) (44) (45) (46) (47) . Exhausted T cells (see below for an explanation) may be found in the environment of chronic infections and cancer cells often display increased expression of inhibitory receptors, including CTLA4 and programmed death receptor 1 (PD-1) (45, 48) .

Naïve T cells have relatively low metabolic activity (49) , but in response to activating stimuli, metabolic activity is rapidly increased (50) . This rapid response is possible due to increased nutrient uptake post stimulation. This may occur concomitant with the presence of untranslated mRNA, idle ribosomes, rapid turnover of transcription factors required for T cell activation, and the presence of an abundance of most of the glycolytic enzymes in quiescent T cells. Together this facilitates upregulation of protein, DNA and lipid synthesis (51, 52) . Perturbation of the TCR/CD3 complex and the CD28 marker is further associated with activation of Calcium Calmodulindependent protein kinase 2 (CaMKK2) (53) . CaMKK2 is known to activate the energy sensor AMP-dependent protein kinase (AMPK) in T cells (54, 55) . AMPK is an energy sensor, which is mainly activated by low levels of ATP and liver kinase B1 (LKB1)-dependent phosphorylation (56) . Although AMPK is commonly activated in response to an increased ADP/ATP ratio, TCR/CD3-CD28 signaling increases mitochondrial biogenesis and activation of this energy associated enzyme independently of the ADP/ATP ratio (55) . This suggests that AMPK activation and increased mitochondrial biogenesis is induced in preparation for the energy demands required for T cell growth and proliferation. Engagement of TCR/CD3-CD28 also promotes recruitment of PI3K and activation of Akt in the immune synapse. This regulates the activity of the mammalian target of rapamycin, mTOR/raptor complex 1 (mTOR complex 1/mTORC1) through inhibition of the key upstream regulator tuberous sclerosis complex 2 (TSC2), which functions as a GTPase activity protein (GAP) for Ras homolog enriched in brain (Rheb) GTPase (57) . mTOR kinase forms two distinct protein complexes, mTORC1 and mTORC2, which are crucial for driving differentiation of CD8+ and CD4+ T cells (58) . The mTORC1 complex is defined as regulatory-associated protein of mTOR (RAPTOR), while mTORC2 is defined as rapamycin insensitive companion of mTOR (RICTOR) (57) .

The GTP-bound form of Rheb directly interacts with mTORC1, which tunes the induction and activity of several transcription factors involved in regulation of mitochondrial activity and biomass production. This includes sterol regulatory element-binding proteins (SREBP) hypoxiainducible factor 1a (HIF-1a) and MYC, resulting in increased glycolysis, glutaminolysis and lipid synthesis (59) . mTORC2, on the other hand, is more involved in fatty acid oxidation and negatively regulates CD8+ T cell memory differentiation through Akt-dependent phosphorylation of forkhead box protein O1 (FOXO1) resulting in cytosolic retention (60, 61) . mTORC2 directly phosphorylates Akt on Serine 473, thereby, promoting the expression of glucose transporter 1 (GLUT1), activating hexokinase 2 (HK-2) and phosphofructokinase-1 (PFK-1), phosphorylation and expression of 2-phosphofructkinase 6/ fructose 2,6-bisphosphatase (PFKFB)-3 and 4. This promotes in increased glucose uptake and glycolysis (summarized in Figure 1 ) (62) (63) (64) (65) . TCR/CD3-CD28 stimulation is further associated with induction of lactate-dehydrogenase A (LDHA) that converts pyruvate to lactate (66) . This metabolic reprograming of T cells result in increased glycolysis and lactate production despite presence of oxygen (67) . This process is commonly referred to as the Warburg effect and supports accumulation of glycolytic intermediates that can enter the pentose phosphate pathway (PPP), to produce ribose 5-phosphate (R5P), which is used in nucleotide synthesis. The Warburg effect is also associated with the production of nicotinamide adenine dinucleotide phosphate (NADPH), which has two main functions; it acts as a redox agent and is essential as an electron donor in anabolic biomass synthesis (67, 68) . TCR/CD3 and CD4/CD8-induced PTK activity phosphorylates the muscle form of pyruvate kinase (PKM2) leading to nuclear localization of PKM2 dimers, which participate in regulating gene expression rather than glycolysis (69) . In fact, regulation of PKM2 activity is a key factor together with pyruvate dehydrogenase kinase 1 (PDK1) in preventing pyruvate entering the mitochondrion. PDK1 inhibits the enzyme pyruvate dehydrogenase (PDH), which catalyzes the formation of acetyl co-enzyme A (AcCoA) and TCA cycle entry. This leads to accumulation of pyruvate in the cytosol, which is used to produce lactate and regenerate NAD+ from NADH (70, 71) .

Many proliferating cells, including TCR/CD3-CD28 stimulated T cells, may adopt profiles associated with oxidative phosphorylation (OXPHOS) when glucose is limited. This is achieved by increased uptake and metabolism of the amino acid glutamine (72) . This requires upregulation of the glutamine transporter, alanine-serine-cysteine transporter 2 (ASCT2/ SLC1A5) and differential regulation of the glutaminase (GLS) isoforms, kidney glutaminase (KGA) and glutaminase C (GAC) (73, 74) . TCR/CD3-CD28 co-stimulation upregulates expression of GAC, while downregulating KGA. GLS catalyzes the deamidation of glutamine to glutamate, which is the first step of glutaminolysis. Glutaminolysis is mainly regulated through MYC-induced expression of key genes (75) . Glutamine metabolism is crucial for proliferating cells as it is involved in several metabolic pathways. This includes production of aketoglutarate (a-KG) from glutamate and alanine by transferring the amino group from glutamate to pyruvate by alanine aminotransferase (ALT) (76) . The product, a-KG may enter the TCA cycle to form citrate. Citrate can be shunted out of the mitochondrion to support cytosolic AcCoA levels and used as a substrate lipogenesis and mevalonate metabolism as well as cholesterol synthesis (77, 78) . a-KG may also support production of carbon intermediates in the TCA cycle and the production of reduced forms of the electron donors NADH and flavin adenosine dinucleotide (FADH) required for OXPHOS (79) . Glutaminolysis also supports production of NADPH through the PPP and TCA cycle, which along with glutamate and cysteine, is used to produce the antioxidant glutathione (GSH) (80, 81) . Finally, glutaminolysis provides both carbon and nitrogen residues used for synthesis of polyamines, amino acids and DNA and RNA nucleotides (82) . Inhibition of glutaminolysis as well as reduced ornithine and putrescine synthesis decrease T cell proliferation, highlighting the important role of glutaminolysis (83) .

As glutamine has a central role in proliferating cells, including activated T cells, glutamine is sometimes referred to as a conditionally essential amino acid. In fact, exogenous glutamine deprivation and inhibition of glutaminolysis prevent T cell activation, proliferation and clonal expansion (84) . This reliance on glutamine metabolism is sometimes referred to as "glutamine-addition". Glutamine-dependent anapleurosis is further known to dictate glucose uptake and glycolysis in proliferating cancer cells (85, 86) . Extracellular glutamine depletion is also associated with metabolic reprogramming, as glutamine synthetase (GS) converts glutamate to glutamine, is FIGURE 1 | T cell receptor perturbation drives metabolic reprograming. T cell activation by ligation of the TCR and CD28 cell surface marker induces metabolic reprograming through activation of protein kinases that induces calcium dependent activation of the AMPK pathway to induce synthesis of mitochondria. In addition, mTORC1 activation induces lipid synthesis and enhances lipid synthesis, glutaminolysis and glycolysis required for rapid proliferation, whereas mTORC2 induces glucose uptake and glycolysis while repressing fatty acid oxidation. Figure was created using assets from Servier Medical Art, licensed under a Creative Common Attribution 3.0 Generic License. (http://smart.servier.com/). APC, antigen presenting cell; TCR, T cell receptor; PI3K, phosphatidylinositol kinase 3; CaMK II, calcium calmodulin-dependent kinase II; AMPK, adenosine monophosphate-dependent kinase; TSC2, tuberous sclerosis complex 2; Rheb, RAS homolog enriched in the brain; LKB1, liver kinase B1; SREB, sterol regulatory element-binding proteins; HIF-1a, hypoxia-inducible factor 1 a; mTORC, Mechanistic target of rapamycin complex; GLUT1, Glucose transporter 1; FOXO1, forkhead box O1; FAO, fatty acid oxidation; HK1, hexokinase 1; PFK-1, phosphofructokinase 1.

upregulated (87) . Glutamine anapleurosis can also be used to produce the amino acid asparagine, which in addition to being important for protein synthesis, is also regulating activation of T cells by directly enhancing Lck activity (88) (89) (90) . In response to glutamine deprivation, asparagine becomes an essential amino acid. Despite this, mammals do not possess functional asparaginase, the enzyme required for asparagine to re-enter the TCA cycle (89) . In fact, ectopic expression of the catalytically active asparaginase inhibits cell growth and proliferation by redirecting asparagine to the TCA cycle rather than protein synthesis (89, 91) . Arginine is another amino acid important for T cell activation, and supplementation of extracellular arginine increases long-term survival and effector functions of T cells, accompanied by a reduction in glycolysis and enhanced oxidative phosphorylation (92) . T cell activation and clonal expansion also require uptake of the amino acids cysteine, methionine and the branched chain amino acid (BCAA) leucine. While naïve T cells do not express transporters for cysteine and cystine, this is rapidly induced by CD3/CD28-induced activation. In early activation, uptake of cysteine and methionine is crucial for proliferating T cells (93) . Leucine is important for determining the fate of CD4+ T cells as it regulates activation of mTORC1. During leucine depletion the leucine sensor sestrin 2 (SESN2) binds to the GTPase-activating protein towards Rags-2 (GATOR2), forming an inhibitory complex towards mTORC1 (94, 95) . Loss of the leucine transporter SLC7A5/LAT1 (CD98) limits T cell activation and effector maturation owing to impairments in mTORC1 activity (96) . Finally, serine is used for one-carbon metabolism and purine synthesis through the B vitamin 10-formyltetrahydrofolate. Serine also supports 5methyltetrahydrofolate, and generation of the methyl donor Sadenosyl methionine (97) .

In addition to nutrient availability, oxygen tension also varies greatly in different tissues. Many lymphoid organs, including spleen and thymus, are known to have low oxygen levels and are considered to be in a state of physiological hypoxia (<4% O 2 ) (98). T cells, which are highly mobile in nature encounters a wide range of oxygen levels in the body. For example, during thymic development, thymocytes inhabit within relatively low oxygen (< 1%). Activated T cells are faced with both high oxygen levels in the lungs and arterial blood as well as the hypoxic and anoxic conditions in inflammatory lesions and tumors (99) (100) (101) . As low oxygen concentration is metabolically challenging, hypoxia induces metabolic programs required to adapt to the environment. T cell differentiation, function and survival is known to be affected by exposure to hypoxia, a response mainly mediated by the transcription factor HIF-1a, directly or indirectly (98) . HIF-1a, is stabilized and heterodimerizes with the constitutively expressed HIF-1b, also known as aryl hydrocarbon receptor nuclear transporter (Arnt) under hypoxic conditions. The HIF complex translocate into the nucleus where it binds to hypoxia response elements (HREs) (102) . In the presence of oxygen, HIF-1a is rapidly degraded by the enzyme prolyl hydroxylase domain proteins (PHD) 1, 2 and 3, thus the HIF-1a complex has limited transcriptional activation capacity in normoxia. HIF-1a induces a metabolic shift by inducing a glycolytic phenotype mediated by increased expression of genes involved in glucose uptake and glycolysis, including GLUT1, HK2, PKM2, LDHA, while actively reducing glucose oxidation through the expression of PDK1 (102) (103) (104) . This indicates that HIF-1a induces a metabolic phenotype where glycolysis is the primary source for ATP. As pyruvate is shunted towards lactate, rather than the TCA cycle, this reduces the ability to produce citrate. To compensate for this, cells at hypoxia produce citrate and cytosolic AcCoA required for fatty acid synthesis through glutaminolysis. In this case, a-KG is metabolized to citrate through the TCA cycle in a reverse fashion by reductive carboxylation. These reactions are catabolized by the two isocitrate dehydrogenase (IDH) isozymes, IDH1 and IDH2, which are induced by low oxygen (105, 106) . This demonstrates that during hypoxia, HIF-1a drives T cells to adapt a metabolic phenotype relying on glycolysis and glutaminolysis to support proliferation and clonal expansion.

In addition to its role in early activation, it has become increasingly clear that distinct metabolic programs define the various T cell subsets ( Figure 2 ) (107). It is also known that T cell differentiation can be manipulated through modulating metabolic activity in vitro (108) (109) (110) . However, the extent of how metabolism affects T cell function in response to infection is not fully understood.

As mentioned, naïve T cells generate most of their ATP from oxidative phosphorylation and in general display a less energetic state than activated T cells yet can rapidly reprogram metabolism upon activation (50, 111, 112) . This rapid response towards antigen is likely made possible by the rapid turnover of proteins (51) . While this metabolic reprograming stems, at least in part, from an increased demand for ATP to fuel rapid proliferation, there is also increasing evidence that fine-tuning of specific metabolic pathways drive differentiation into various subsets. This is best characterized for the Th1, Th2 and Th17 subsets.

Th1, Th2 and Th17 cell differentiation induces three distinct metabolic phenotypes. However, all subsets have a relatively high rate of glycolysis when compared to Tregs, naïve or memory T cells (113) . While Glucose is known to be crucial for T cells to produce IFNg, as cells cultured in galactose have severely reduced IFNgsecretion. This has been linked to the dual role of the enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH), as it can bind to, and repress translation of IFNg mRNA (110) . This was shown to be related to glucose-derived mannose combustion. Supplementation with mannose could partially restore IFNg production in cells cultured with the glycolysis inhibitor 2-deoxy-D-glucose (2DG). Interestingly, the transcription factor T-bet, which is crucial for Th1 differentiation, was reduced when cells were cultured in the presence of galactose, but was restored by mannose supplementation (114) . Lastly, inhibition of GLS-1 has been shown to increase Th1 differentiation (73) . Th2 cells are reportedly the most glycolytic of the Th subsets, correlating with high expression of GLUT1 and low rate offatty acid oxidation (113) . mTORC2, which as previously mentioned, is an important regulator of fatty acid oxidation and glycolysis, is also important for differentiation of Th1 and Th2 cells through distinct mechanisms. Th1 cells depend on mTORC2-dependent phosphorylation of Akt, while Th2 cells depend on phosphorylation of PKC (115) . Peroxisome proliferation activating receptor-g (PPAR-g), which is a regulator of fatty acid metabolism, is also involved in promoting Th2 differentiation while repressing Th1 differentiation (116) . Th17 differentiation induces a metabolic phenotype distinct from both Th1 and Th2 cells. Th17 differentiation requires HIF-1a stabilization and induction of PDHK1, preventing mitochondrial pyruvate oxidation in favor of lactate production (71, 104, 117) . GLS1-dependent glutamine metabolism is also a crucial factor for Th17 differentiation (109) . GLS1 expression in T cells can be induced by the transcription factor inducible cAMP early repressor (ICER) (109) . Blocking GLS1 shifts Th17 cells to a Th1-like phenotype (73) . Th17 differentiation also requires fatty acid synthesis (118) . The metabolic phenotype of Th9 and Th22 cells is not as extensively studied compared to that of the other CD4+ effector cells. However, Th9 cells have a higher glycolytic rate than both Th2 and Th17 cells, and require activation of mTORC1 and HIF-1a (119).

Treg differentiation depends on the oxidation of long fatty acids, induced by activation of AMPK (113) . Although Tregs upregulate glycolysis compared to naïve cells this is to a lesser degree than the effector CD4+ T cells and it is not necessary to support Treg differentiation (113, 120) . In support of this Treg differentiation is inhibited in favor of Th17 differentiation by HIF-1a-induced glycolysis (117, 121) . In fact, increasing glucose uptake and glycolysis in Tregs represses suppressor functions despite increasing proliferation (122, 123) . Compared to effector CD4+ T cells, Tregs depend on fatty acid oxidation to fuel mitochondrial respiration (120) . Treg differentiation may also be reduced by the presence of exogenous amino acids including glutamine, tryptophan and arginine (124) . Lastly, extracellular lactate may enhance Treg function through uptake via the monocarboxylate transporter 1 (MCT1) (123) .

Memory subsets of T cells are characterized by a reliance on fatty acid oxidation and low rate of glycolysis (125) . Supplementing the amino acid arginine has been shown to enhance memory formation and reprogram T cells from a glycolytic to an oxidative phenotype (92) . Similar to naïve T cells, memory T cells have a rapid turnover of proteins related to activation, including glycolytic enzymes (51) . The microenvironment is also important for modulating T cell activity and metabolism. Recently, it was discovered that T cells create acidic niches within lymphoid organs to dampen effector functions (126) . This is also well-defined in the tumor microenvironment (TME), which is characterized by the presence of anti-inflammatory cytokines, low levels of oxygen and acidification by lactate (127) (128) (129) (130) . In rheumatoid arthritis the microenvironment of the synovium exerts pro-inflammatory effects on the CD4+ T cells by repressing glycolytic rate (131) . It is further known that increased body temperature may enhance proliferation and effector functions of both CD4+ and CD8+ T cells (132, 133) Together this demonstrates how the microenvironment may shape T cell activity.

T cell exhaustion is featured in both cancer and persistent infections. Exhausted T cells can be defined by an increased expression of inhibitory ligands, including PD-1 and CTLA-4 and are more apoptotic than effector and memory cells (48, 134) . Exhausted T cells also display a distinct metabolic phenotype, with reduced glucose uptake as well as mitochondrial dysfunction, which reduces capacity for oxidative metabolism. The presence of extracellular metabolites as well as low abundance of important nutrients may further inhibit metabolism and prevent the appropriate T cell activity (135, 136) .

As detailed above, T cell metabolism and functionality are closely related and metabolic reprograming is crucial for appropriate T cell activity. In this section, we will briefly describe how T cell metabolism is regulated in certain acute infections and how T cell metabolism may aid or hinder pathogen clearance under acute and chronic conditions of infection. We will use examples of virus infections by SARS-CoV-2 and HIV as these viruses are known to induce differential effects on T cell metabolism. We will also briefly describe T cell metabolism in bacterial infections, here exemplified by infections of Mycobacterium tuberculosis.

When T cells are engaged in the immune response, they can be roughly divided into naïve, effector and memory cells, each with accompanying metabolic programs (137). The immune system, when properly regulated will have a protective role. However, in some cases the immune system might exasperate the inflammation associated with infection (138) . This is apparent for SARS-CoV-2 infections, which cause the well-known coronavirus disease 2019 (COVID-19) . Despite that the underlying molecular mechanism responsible for sustaining SARS-CoV-2 virulence is enigmatic, how SARS-CoV-2 attaches on the surface of host cells through a variety of receptors is in part well described. Attachment may be through receptors, such as angiotensin converting enzyme 2 (ACE2), neuropilin-1 (NRP1), AXL, and antibody-FcgR complexes (139) . ACE2 is expressed in various human organs and may play a role in regulating cardiovascular and renal function. In addition, the ACE2 protein is a functional receptor for the spike glycoprotein of the human coronavirus and is considered a causative agent of COVID-19 disease. Next, NRP1 is a membrane-bound coreceptor to a tyrosine kinase for both vascular endothelial growth factor (VEGF) and semaphorin (SEMA3A) family members, both playing versatile roles in angiogenesis, axon guidance, cell survival, migration, and invasion. Furthermore, the gene AXL, which encodes the tyrosine-protein kinase receptor UFO, is involved in stimulation of cell proliferation and survival through PI3K-AKT-mTOR, MEK/ERK, NF-kB, and JAK/STAT activation (140) (141) (142) (143) . In line with the fact that COVID-19 uses receptor ligation for infection, several reports reveal that COVID-19 ligation through and activation of the above-mentioned signal transduction molecules, induces metabolic reprogramming (144, 145) . In fact, this metabolic reprograming can be detected by positron emission tomography (PET) by increased accumulation of 18 F labelled fluorodeoxyglucose (FDG) (146) . This metabolic reprograming is also associated with a distinct profile of serum metabolites, which might be used as a prognostic measurement of disease severity (147) . It has further been demonstrated that this increased level of FDG in the tissue correlate with increased glycolysis in several cells, including epithelial cells and immune cells, reviewed by Kumar (148) . Notably, peripheral blood mononuclear cells (PBMCs) display metabolic dysfunction, characterized by increased glycolysis and reduced oxygen consumption (149) . SARS-CoV 2-infected monocytes also show enhanced glycolytic rate. Interestingly, the same study reports that increasing extracellular glucose concentration increased SARS-CoV 2 replication in monocytes (150) . Because of this central role of glycolysis in COVID-19 the glucose analog 2-deoxy-D-glucose (2DG), which inhibits glycolysis, has undergone a phase III trial and received emergency approval in the treatment of moderate and severe COVID-19 in India. However, the trial was conducted in only 220 patients and the data has not been made available to the public (151) . In this review we have mainly focused on the metabolism of T cells in response in COVID-19.

In both CD4+ and CD8+ T cells COVID-19 inhibits activation of mTORC1, which reduces glycolytic activity, as well as causing mitochondrial dysfunction and increased susceptibility to apoptosis ( Figure 3 ) (145) . In line with this, expression levels of GLUT1 are reported to be decreased in T cells in patients with severe COVID-19 as compared to healthy controls or patients infected by influenza virus. However, contradictory results exist. A study by De Biasi et al., showed with one exception that T cells from COVID-19 patients had a similar capacity for metabolic reprogramming to non-infected T cells (152) . However, the COVID-19 patients all required respiratory aid, while most patients in the latter study had pO 2 >90%. This might indicate a link between metabolic alteration, mitochondrial dysfunction and declining oxygen saturation (145, 152) . This is supported by a study by Siaska et al., where T cell metabolism was differentially affected in mild compared to moderate and severe disease. This was evident by an elevated uptake of fatty acids in T cells from patients with mild or no symptoms, while glucose uptake was similar to that of quiescent T cells from healthy controls (153) . This study also revealed that moderate and severe disease was correlated with increased mitochondrial content, ROS and expression of basigin, which is reported to drive hyperinflammation and bone degradation in rheumatoid arthritis (153, 154) .

Several studies have shown that recovered COVID-19 patients display symptoms for weeks or months after disease onset, commonly referred to as "long COVID" (155) (156) (157) . These symptoms include chest pains, joint pains, cognitive disorders, anxiety, depression and neurological disorders. Long COVID even affects individuals who initially had mild symptoms upon infection (155, 156, 158) . Interestingly, T cells from COVID-19 patients reportedly have increased levels of triple methylated histone 3 lysine 27 (H3K27me 3 ), a potentially epigenetic effect that persists in recovered patients (159) . Reports demonstrate that the H3K27me 3 modification represses T cell activation, differentiation and metabolic activity, by inhibiting expression of several transcription factors involved in metabolic regulation. These include MYC, PPARg and peroxisome proliferatoractivated receptor gamma coactivator-related protein 1 (PPRC1) (Figure 3) (160, 161) . A recent study demonstrates a correlation between neurologic symptoms in recovered patients and T-cell immune reactivity. Patients with neurologic symptoms were also shown to have a distinct T-cell phenotype compared to healthy COVID convalescents. Notably, in individuals with long COVID Tfh cells had increased reactivity to the nucleocapsid of the SARS-CoV-2 virus, while the COVID convalescents showed reactivity towards spike proteins (157) . This is consistent with an earlier study revealing that T cells from patients with neurological symptoms following COVID-19 recovery, displayed a distinct reactivity. The same study also showed an increase in the population of exhausted CD4+ T cells (162) . Whether these effects are related to the epigenetic changes induced by methylation of H3K27 is not clear. Further studies will be needed to determine how T-cell metabolism and metabolic dysfunction are correlated to COVID-19 disease severity and if similar phenomena can be found for other infectious agents.

As T-cell metabolism is correlated to both short-term survival and long-term effects further studies of T-cell metabolism in COVID-19 may result in better stratification of patients as well as offering new therapeutic targets to minimize the impact of COVID-19.

The excessive immune response for severely affected patients may be caused by so called cytokine storms, which is simply defined as release of too many cytokines into the blood too quickly (163) . In patients where this occurs, coupled with inability to clear infection leads to chronic infection, a condition leading to T-cell exhaustion (137) . Exhausted T cells are characterized by an increased expression of inhibitory markers and a progressive and hierarchical loss of function as seen in HIV infections, where HIV is the causative agent for acquired immunodeficiency syndrome (AIDS) (164) . HIV target the CD4 cell surface marker, allowing infection of CD4+ T cells and Mø (165) . During the acute phase of HIV infection, most patients experience a marked increase in HIV viral load coupled with increased levels of the PD-1 receptor on HIV-infected T cells. Untreated patients will in this case experience T-cell exhaustion. The positive effects of antiretroviral therapy (ART), which in most cases significantly inhibits viral replication, also lowers high PD-1 expressing T cells, suggesting a link between viral load and the level of PD-1 expressing T cells (166, 167) . The HIV virus infects cells by first interacting with CD4, followed by interaction with the chemokine receptor CCR5 on Mø or CXCR4 on T cells (168) . In addition to CD4 and CXCR4, HIV is reported to exploit GLUT1 to infect T cells (169) . GLUT1 expression has been shown to be elevated on circulating CD4+ T cells in patients with chronic HIV-1 infection. As HIV-induced surface expression of GLUT1 coincide with increased glucose uptake and increased glycolytic activity (Figure 4) (170, 171) it is likely that such a metabolic pattern mirror HIV infected CD4+ T cells in AIDS patients. Recently, it was demonstrated that in acute HIV-1 infections, viral replication is correlated with increased expression of nucleotide-binding domain leucine-rich repeatcontaining receptor X1 (NLRX1). NLRX1 is most likely required for the HIV-induced metabolic reprograming of CD4+ T cells and leads to increased glycolysis and oxygen consumption. Interestingly, blocking glycolysis using the glucose analogue 2DG or mitochondrial respiration using rotenone or metformin inhibits HIV replication in CD4+ cells (171) . This is in line with the fact that CD4+ T cells cultured with the simple sugar galactose exhibit less viral replication and reduced HIVinduced cell death, supporting that HIV infections requires glycolytic activity (172) . Furthermore, some HIV-infected patients maintain low virus titers even without ART. This was associated with distinct HIV-specific CD8+ T cells. Such CD8+ T cells can be distinguished from CD8+ T cells from patients sensitive to ART. In the ART-insensitive patients, the CD8+ T cells expressed enhanced levels of mTORC2 and increased fatty acid oxidation. and ART-insensitive patients were further associated with formation of increased numbers of CD8+ memory T cells Interestingly, in ART treated CD8+ T cells, treatment with IL15 reflected increased mTORC2 expression and a fatty acid consuming phenotype (173) . In line with these observations, T-cell metabolism may have prognostic potential, and may even provide therapeutic targets in cases of HIV infections. The current knowledge of T-cell metabolism in HIV infection indicates that the HIV virus exploits the glycolysis of CD4+ T cells to both infect and enhance replication rate, while high glycolytic rate of CD8+ T cells confer resistance to infection (170, 171, 173) . Hence, both CD4+ and CD8+ T-cell metabolic profiles may serve as prognostic markers of the patients. In line with this, it is speculated that targeting glycolysis of e.g., CD4+ T cells may reduce T-cell replication in patients suffering from viral infection, such as by HIV. Importantly, this understanding of metabolism in HIV indicates a potential for repurposing metformin for the management of HIV infection (171) . Together, this highlights the importance of further studies to determine the efficacy of metabolic inhibition in the management of HIV infection.

Tuberculosis remains a major threat to human global health, with an estimated one-fourth of the world population latently infected (174) . Tuberculosis is caused by Mycobacterium tuberculosis (MT) infection. T cells and Mø are crucial players in the anti-mycobacterial host defense and in containing the spread of mycobacteria during latent disease (175) . This is highlighted by the observation that HIV-induced depletion of CD4+ T cells and the level of PD-1 expression leads to increased co-morbidity in MT-infected individuals (176, 177) . Together this points to the importance of stringent regulation of CD4+ T cells in defense against MT infection.

With an increasing body of evidence, it is argued that metabolic changes at the cellular level, is vital to mount an effective immune response to MT. This include pathways found to be necessary for the full activation of lymphocytes and include regulation of cytokine production, pyrimidine metabolism, as well as production of glutathione and large amounts of mitochondrial reactive oxygen species (ROS) in response to MT infection (178) . To this end, the mitochondrial matrix protein Cyclophilin D (CypD) acts as a peptidyl-prolyl cis-trans isomerase that regulates the mitochondrial permeability transition pore (PTP). PTP is a nonspecific large conductance pore when open leads to cell death. PTP expression has been implicated in ischemia/ reperfusion injury in multiple organs, in neurodegenerative disorders, and in muscular dystrophies (179, 180) . Interestingly, loss of CypD is implicated in metabolic changes, which include increased aerobic glycolysis, mitochondrial OXPHOS, and consumption of glucose and glutamine. This is further associated with increased T-cell activation to proliferation and cytokine production, such as TNFa and IFNg. Moreover, MT infection in CypD ablated individuals, lead to immunopathology caused by T-cell dysfunction, however, without affecting bacterial burden. Moreover, CypD-deficient mice succumbed earlier to infection than wild-type mice stressing the role of CypD and dysregulated T-cell function potentially associated with altered immune cell metabolism in MT infections (181) . It is also reported that both early and long-term MT infection induces distinct defects to the metabolism of CD8+ T cells. MT infection increases expression of both PD-1 and CTLA4, which further correlates with decreased glucose uptake as well as reduced glycolysis and mitochondrial respiration. This further reflects a repressed metabolic programing normally induced by stimulation of the anti-CD3/CD28 complex (182) .

As the tissue microenvironment also affects the effector functions and metabolism of T cells, targeting metabolic pathways can also affect T-cell activity indirectly. This is the case for MT-induced granulomas, in which Mø catabolize tryptophan and secrete transforming growth factor b (TGF-b) to create an immunosuppressive environment (178, 183, 184) . Hence, the capability of T cells in clearing MT infections is largely limited by the inability to enter the granulomas in which MT induces expression of indoleamine 2,3-dioxygenase (IDO), and tryptophan catabolism to form the immunosuppressive metabolite kynurenine (185, 186) . Moreover, IDO expression has previously been linked to a decline in IFNg, demonstrating how MT-induced changes in Mø metabolism may induce tolerance and prevent clearance (183) . This likely occurs through interaction between kynurenine and the aryl hydrocarbon receptor (AHR) in combination with TGF-b, which drives Treg differentiation ( Figure 5 ) (187). In conclusion, MT infections contribute to decreased T cell glycolytic metabolism through several mechanisms. Despite that the knowledge is sparse, such changes may further have implications for how and to what extent the immune system is able to counteract a MT infection and to what extent the immune system may be capable to eradicate the MT bacteria.

We have briefly summarized some knowledge on T-cell metabolism in situation of infections by virus and bacteria. Research over the last couple of decades have revealed that Tcell metabolism is closely linked, not only to proliferation and clonal expansion, but that cell-specific metabolism also dictate cell differentiation programs and reflect effector functions (136) . As detailed here, T-cell metabolism may in addition aid pathogen clearance or confer resistance to infections by virus and bacteria. However, in some cases T-cell metabolism may be displayed as T-cell exhaustion leading to tolerance, or even support of inflammation. The latter is displayed in certain cases of viral infection, where immune cell metabolism also supports viral replication (135, 169, 170, 181, 182) .

Modulating T-cell metabolism by supplementation with key nutrients or employing inhibitors of key metabolic pathways has previously been shown to enhance memory formation or enhance effector function of T cells in cancer, or even induce pro-inflammatory and migratory programs (92, 108, 188, 189) .

As T-cell exhaustion is a feature in both persistent infection and cancer it is expected that reversing the exhausted phenotype will have markedly clinical potential (190) . T-cell metabolism may also be important in both the acute and long-term effects of COVID-19, making it an interesting target for therapeutic applications (145, 155, 159, 162) .

As detailed in this review, metabolic reprograming of T cells is crucial for conveying protection against infectious pathogens. On the other hand, some pathogens may exploit or modify T cell metabolism to prevent the appropriate effector functions. Further research is needed to determine if targeting dysfunctional T cell metabolism may be used therapeutically in infectious diseases to enhance effector functions and reverse T-cell exhaustion in chronic infections.

JW and BS both conceived and drafted this review and contributed to final proof and approval of the submitted version.

Grant from Thorn Holst 2020-2021 to BS.

The Skin and Intestinal Microbiota and Their Specific Innate Immune Systems

Janeway's Immunobiology

Recognition of Microorganisms and Activation of the Immune Response

PAMPs and DAMPs: Signal 0s That Spur Autophagy and Immunity

Molecular Biology of the Cell

The CD8 T Cell Response to Respiratory Virus Infections

Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, But Not Direct Granzyme B-Mediated Caspase Activation

Plasticity of Human CD4 T Cell Subsets

Th1/Th2 Balance in Infection

Th17 Cells at the Crossroads of Innate and Adaptive Immunity Against Infectious Diseases at the Mucosa

Deficiency of Th17 Cells in Hyper IgE Syndrome Due to Mutations in STAT3

Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases

Production of Interleukin 22 But Not Interleukin 17 by a Subset of Human Skin-Homing Memory T Cells

The Role of IL-22 and Th22 Cells in Human Skin Diseases

IL-9 and Th9 Cells in Health and Diseases-From Tolerance to Immunopathology

Emerging Roles of Th9 Cells as an Anti-Tumor Helper T Cells

Cytotoxic CD4 T Cells-Friend or Foe During Viral Infection? Front Immunol

The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases

Role of Th1 and Th17 Cells in Organ-Specific Autoimmunity

Immunologic Influences on Allergy and the TH1/TH2

The Biology and Functions of Th22 Cells

Th9 Cells Represent a Unique Subset of CD4(+) T Cells Endowed With the Ability to Eradicate Advanced Tumors

T Cell Responses: Naïve to Memory and Everything in Between

How do Regulatory T Cells Work?

The Spectrum of T Cell Metabolism in Health and Disease

Metabolic Coordination of T Cell Quiescence and Activation

Hallmarks of T-Cell Exit From Quiescence

T Cell Activation

The Structural Basis of T-Cell Receptor (TCR) Activation: An Enduring Enigma

ZAP-70: An Essential Kinase in T-Cell Signaling

Phosphorylation of Tyr319 in ZAP-70 Is Required for T-Cell Antigen Receptor-Dependent Phospholipase C-Gamma1 and Ras Activation

NFAT and NFkappaB Activation in T Lymphocytes: A Model of Differential Activation of Gene Expression

Physiologic Activation of T Cells via the T Cell Receptor Induces NF-Kappa B

Activation of Interleukin-2 Gene-Transcription Via the T-Cell Surface-Molecule Cd28 Is Mediated Through an Nf-Kb-Like Response Element

Identification of a Putative Regulator of Early T-Cell Activation Genes

AP-1 Transcriptional Activity Requires Both T-Cell Receptor-Mediated and Co-Stimulatory Signals in Primary T Lymphocytes

Signaling and Function of Interleukin-2 in T Lymphocytes

CD28 Costimulation: From Mechanism to Therapy

The CD28 Signaling Pathway Regulates Glucose Metabolism

CD28 Provides T-Cell Costimulation and Enhances PI3K Activity at the Immune Synapse Independently of Its Capacity to Interact With the P85/P110

New Inhibitory Signaling by CTLA-4

CD28 and CTLA-4 Coreceptor Expression and Signal Transduction

Role of CD80, CD86, and CTLA4 on Mouse CD4(+) T Lymphocytes in Enhancing Cell-Cycle Progression and Survival After Activation With PMA and Ionomycin

Molecular and Cellular Insights Into T Cell Exhaustion

CTLA-4 Suppresses Proximal TCR Signaling in Resting Human CD4(+) T Cells by Inhibiting ZAP-70 Tyr(319) Phosphorylation: A Potential Role for Tyrosine Phosphatases

CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy

Defining 'T Cell Exhaustion'

Regulation of T Lymphocyte Metabolism

Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions

Dynamics in Protein Translation Sustaining T Cell Preparedness

Metabolic Pathways in T Cell Activation and Lineage Differentiation

Calcium/calmodulin-Dependent Protein Kinase II Regulates IL-10 Production by Human T Lymphocytes: A Distinct Target in the Calcium Dependent Pathway

Calcium/calmodulin-Dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology

Regulation of the Energy Sensor AMP-Activated Protein Kinase by Antigen Receptor and Ca2+ in T Lymphocytes

AMPK: A Key Sensor of Fuel and Energy Status in Skeletal Muscle

mTOR at the Crossroads of T Cell Proliferation and Tolerance

mTORC1 and mTORC2 Selectively Regulate CD8⁺ T Cell Differentiation

mTOR and Metabolic Regulation of Conventional and Regulatory T Cells

mTORC1 and mTORC2 Selectively Regulate CD8(+) T Cell Differentiation

Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner

Inhibition of Early Apoptotic Events by Akt/PKB Is Dependent on the First Committed Step of Glycolysis and Mitochondrial Hexokinase

Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 Translocation

Role of Akt/PKB and PFKFB Isoenzymes in the Control of Glycolysis, Cell Proliferation and Protein Synthesis in Mitogen-Stimulated Thymocytes

C-MYC Responds to Glucose Deprivation in a Cell-Type-Dependent Manner

Aerobic Glycolysis Promotes T Helper 1 Cell Differentiation Through an Epigenetic Mechanism

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

The Emerging Facets of Non-Cancerous Warburg Effect

Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4(+) T Cell Pathogenicity and Suppresses Autoimmunity

NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act Between Mitochondria and the Nucleus

Metabolic Programming and PDHK1 Control CD4+ T Cell Subsets and Inflammation

Starved Human T Lymphocytes Keep Fighting

Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism

Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation

The Transcription Factor Myc Controls Metabolic Reprogramming Upon T Lymphocyte Activation

Elevation of Alanine Aminotransferase Activity Occurs After Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors But Before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV Infection

The Role of Metabolic Reprogramming in T Cell Fate and Function

Beyond Aerobic Glycolysis: Transformed Cells can Engage in Glutamine Metabolism That Exceeds the Requirement for Protein and Nucleotide Synthesis

Metabolic Reprogramming in Modulating T Cell Reactive Oxygen Species Generation and Antioxidant Capacity

From Krebs to Clinic: Glutamine Metabolism to Cancer Therapy

Role of Polyamines in Immune Cell Functions

T-Cell Metabolism Governing Activation, Proliferation and Differentiation; a Modular View

Glutamine-Dependent Anapleurosis Dictates Glucose Uptake and Cell Growth by Regulating MondoA Transcriptional Activity

Ikkb Promotes Metabolic Adaptation to Glutamine Deprivation via Phosphorylation and Inhibition of PFKFB3

T Helper Cell Activation and Expansion Is Sensitive to Glutaminase Inhibition Under Both Hypoxic and Normoxic Conditions

Asparagine Enhances LCK Signalling to Potentiate CD8+ T-Cell Activation and Anti-Tumour Responses

As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid

Role of Glutamine and Interlinked Asparagine Metabolism in Vessel Formation

Asparagine and Glutamine: Co-Conspirators Fueling Metastasis

Activated Human CD4+ T Cells Express Transporters for Both Cysteine and Cystine

Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond

Sestrin2 Is a Leucine Sensor for the mTORC1 Pathway

Control of Amino-Acid Transport by Antigen Receptors Coordinates the Metabolic Reprogramming Essential for T Cell Differentiation

Serine Is an Essential Metabolite for Effector T Cell Expansion

Hypoxia and Hypoxia-Inducible Factors as Regulators of T Cell Development, Differentiation, and Function

Comparison of Tumor and Normal Tissue Oxygen Tension Measurements Using OxyLite or Microelectrodes in Rodents

Hypoxia in the Thymus: Role of Oxygen Tension in Thymocyte Survival

Dysregulated Bioenergetics: A Key Regulator of Joint Inflammation

Hypoxia-Inducible Factors in T Lymphocyte Differentiation and Function. A Review in the Theme: Cellular Responses to Hypoxia

LDH-A Regulates the Tumor Microenvironment via HIF-Signaling and Modulates the Immune Response

HIF-1-Mediated Expression of Pyruvate Dehydrogenase Kinase: A Metabolic Switch Required for Cellular Adaptation to Hypoxia

S-2-Hydroxyglutarate Regulates CD8+ T-Lymphocyte Fate

D-2-Hydroxyglutarate Interferes With HIF-1a Stability Skewing T-Cell Metabolism Towards Oxidative Phosphorylation and Impairing Th17 Polarization

Unraveling the Complex Interplay Between T Cell Metabolism and Function

Metabolic Control of the Scaffold Protein TKS5 in Tissue-Invasive, Proinflammatory T Cells

Transcriptional Factor ICER Promotes Glutaminolysis and the Generation of Th17 Cells

Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis

The Role of the Crabtree Effect and an Endogenous Fuel in the Energy Metabolism of Resting and Proliferating Thymocytes

Sparse Production But Preferential Incorporation of Recently Produced Naive T Cells in the Human Peripheral Pool

Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets

Mannose Metabolism Is Essential for Th1 Cell Differentiation and IFN-g Production

Mammalian Target of Rapamycin Protein Complex 2 Regulates Differentiation of Th1 and Th2 Cell Subsets via Distinct Signaling Pathways

PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action

Control of TH17/Treg Balance by Hypoxia-Inducible Factor

De Novo Fatty Acid Synthesis Controls the Fate Between Regulatory T and T Helper 17 Cells

Histone Deacetylase SIRT1 Negatively Regulates the Differentiation of Interleukin-9-Producing CD4+ T Cells

Differential Regulation of Human Treg and Th17 Cells by Fatty Acid Synthesis and Glycolysis

HIF1alpha-Dependent Glycolytic Pathway Orchestrates a Metabolic Checkpoint for the Differentiation of TH17 and Treg Cells

Foxp3 and Toll-Like Receptor Signaling Balance T(reg) Cell Anabolic Metabolism for Suppression

Metabolic Support of Tumour-Infiltrating Regulatory T Cells by Lactic Acid

Metabolic Pathways Involved in Regulatory T Cell Functionality

T-Cells Produce Acidic Niches in Lymph Nodes to Suppress Their Own Effector Functions

Metabolic Reprogramming in the Tumour Microenvironment: A Hallmark Shared by Cancer Cells and T Lymphocytes

Understanding the Tumor Immune Microenvironment (TIME) for Effective Therapy

Lactate Modulation of Immune Responses in Inflammatory Versus Tumour Microenvironments

Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches

Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4+ T Cell Metabolic Rewiring

Fever and the Thermal Regulation of Immunity: The Immune System Feels the Heat

Fever Supports CD8+ Effector T Cell Responses by Promoting Mitochondrial Translation

T Cell Exhaustion During Persistent Viral Infections

Metabolic and Epigenetic Regulation of T-Cell Exhaustion

Cellular Metabolism Dictates T Cell Effector Function in Health and Disease

CD8+ T Cell Metabolism in Infection and Cancer

Th17 Cytokines in Mucosal Immunity and Inflammation

Molecular Mechanism of Interaction Between SARS-CoV-2 and Host Cells and Interventional Therapy

A Review on Possible Mechanistic Insights of Nitazoxanide for Repurposing in COVID-19

The Role of Neuropilin-1 in COVID-19

AXL Is a Candidate Receptor for SARS-CoV-2 That Promotes Infection of Pulmonary and Bronchial Epithelial Cells

AXL Receptor Tyrosine Kinase as a Promising Anti-Cancer Approach: Functions, Molecular Mechanisms and Clinical Applications

SARS-CoV-2 Infection Rewires Host Cell Metabolism and Is Potentially Susceptible to mTORC1 Inhibition

Metabolic Defects of Peripheral T Cells in COVID-19 Patients

Positron Emission Tomography in the COVID-19 Pandemic Era

The Serum Metabolome of COVID-19 Patients Is Distinctive and Predictive

How Could We Forget Immunometabolism in SARS-CoV2 Infection or COVID-19?

Mitochondrial Metabolic Manipulation by SARS-CoV-2 in Peripheral Blood Mononuclear Cells of Patients With COVID-19

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response Through a HIF-1a/Glycolysis-Dependent Axis

2-Deoxy-D-Glucose: Is This the Final Cure for COVID-19: Or Yet Another Mirage?

Marked T Cell Activation, Senescence, Exhaustion and Skewing Towards TH17 in Patients With COVID-19 Pneumonia

Metabolic Imbalance of T Cells in COVID-19 Is Hallmarked by Basigin and Mitigated by Dexamethasone

A Critical Epitope in CD147 Facilitates Memory CD4+ T-Cell Hyper-Activation in Rheumatoid Arthritis

Persistent Symptoms in Patients After Acute COVID-19

Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers

Neuro-COVID Long-Haulers Exhibit Broad Dysfunction in T Cell Memory Generation and Responses to Vaccination

Post-Acute Sequelae of SARS-CoV-2 Infection: Caring for the 'Long-Haulers'

Metabolic Programs Define Dysfunctional Immune Responses in Severe COVID-19 Patients

H3K27 Methylation Dynamics During CD4 T Cell Activation: Regulation of JAK/STAT and IL12RB2 Expression by JMJD3

Histone H3K27me3 Demethylases Regulate Human Th17 Cell Development and Effector Functions by Impacting on Metabolism

Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid

Synergism of TNF-a and IFN-g Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

The T-Cell Response to HIV

Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections

Role of PD-1 in HIV Pathogenesis and as Target for Therapy

T-Cell Exhaustion in HIV Infection

Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis

Glut1-Mediated Glucose Transport Regulates HIV Infection

Increased Glucose Metabolic Activity Is Associated With CD4+ T-Cell Activation and Depletion During Chronic HIV Infection

Multi-Omics Analyses Reveal That HIV-1 Alters CD4+ T Cell Immunometabolism to Fuel Virus Replication

HIV-1 Pathogenicity and Virion Production Are Dependent on the Metabolic Phenotype of Activated CD4+ T Cells

Metabolic Plasticity of HIV-Specific CD8+ T Cells Is Associated With Enhanced Antiviral Potential and Natural Control of HIV-1 Infection

The Global Burden of Latent Tuberculosis Infection: A Re-Estimation Using Mathematical Modelling

Immune Response to Mycobacterium Tuberculosis: A Narrative Review

Interaction Between HIV and Mycobacterium Tuberculosis: HIV-1-Induced CD4 T-Cell Depletion and the Development of Active Tuberculosis

CD4 T Cells Promote Rather Than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition

Metabolic Regulation of Immune Responses to Mycobacterium Tuberculosis: A Spotlight on L-Arginine and L-Tryptophan Metabolism

Cyclophilin D Is a Component of Mitochondrial Permeability Transition and Mediates Neuronal Cell Death After Focal Cerebral Ischemia

The Mitochondrial Permeability Transition Pore: Molecular Nature and Role as a Target in Cardioprotection

Mitochondrial Cyclophilin D Regulates T Cell Metabolic Responses and Disease Tolerance to

Compromised Metabolic Reprogramming Is an Early Indicator of CD8+ T Cell Dysfunction During Chronic Mycobacterium Tuberculosis Infection

IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis

TGF-b-Mediated Inhibition of IFN-g Production by Mycobacterium Tuberculosis-Specific T Cells in the Infected Lung

Granuloma Correlates of Protection Against Tuberculosis and Mechanisms of Immune Modulation by Mycobacterium Tuberculosis

In Vivo Inhibition of Tryptophan Catabolism Reorganizes the Tuberculoma and Au gments Immune-Mediated Control of Mycobacterium Tuberculosis

An Interaction Between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells

Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy

Glutamine-Dependent a-Ketoglutarate Production Regulates the Balance Between T Helper 1 Cell and Regulatory T Cell Generation

T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses

this article, or claim that may be made by its manufacturer, is not guaranteed or

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in